BIOMAT Database Logo BIOMAT Database Logo

Treatment of herpes simplex with 5-iodo-2'-deoxyuridine. 1962

S P HALL-SMITH, and M J CORRIGAN, and M J GILKES

UI MeSH Term Description Entries
D007065 Idoxuridine An analog of DEOXYURIDINE that inhibits viral DNA synthesis. The drug is used as an antiviral agent. 5-Iodo-2'-deoxyuridine,IUdR,Iododeoxyuridine,5-Iododeoxyuridine,Allergan 211,Herplex Liquifilm,Idoxuridine, 123I-Labeled,Idoxuridine, 125I-Labeled,Idoxuridine, 131I-Labeled,Idoxuridine, 3H-Labeled,Idoxuridine, Radical Ion (+1),Idoxuridine, Radical Ion (1-),Kerecide,NSC-39661,Oftan-IDU,SK&F-14287,Stoxil,123I-Labeled Idoxuridine,125I-Labeled Idoxuridine,131I-Labeled Idoxuridine,3H-Labeled Idoxuridine,5 Iodo 2' deoxyuridine,5 Iododeoxyuridine,Idoxuridine, 123I Labeled,Idoxuridine, 125I Labeled,Idoxuridine, 131I Labeled,Idoxuridine, 3H Labeled,Liquifilm, Herplex,NSC 39661,NSC39661,Oftan IDU,OftanIDU
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection

Related Publications

S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
TREATMENT OF HERPES SIMPLEX KERATITIS WITH 5-IODO-2'-DEOXYURIDINE.
August 1963, The British journal of ophthalmology,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
Herpes simplex encephalitis: brain biopsy and treatment with 5-iodo-2'-deoxyuridine.
February 1968, The Journal of pediatrics,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
Herpes simplex encephalitis treated with systemic 5-iodo-2'deoxyuridine.
November 1966, Annals of internal medicine,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
Treatment of herpes simplex of the skin with 5-iodo-2'-deoxyuridine ("Kerecid").
May 1963, Journal of the Irish Medical Association,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
Antiviral substances: treatment of herpes simplex keratitis by 5-iodo-2'-deoxyuridine.
November 1962, The Journal of pediatrics,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
A TRIAL OF 5 IODO-2'-DEOXYURIDINE IN HERPES SIMPLEX.
November 1964, The British journal of dermatology,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
EVALUATION OF 5-IODO-2' DEOXYURIDINE (IDU) IN HERPES SIMPLEX.
March 1965, Oral surgery, oral medicine, and oral pathology,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
[Sensitivity of herpes simplex virus to 5-iodo-2'-deoxyuridine].
December 1965, Giornale di malattie infettive e parassitarie,
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
Use of 5-iodo-2'-deoxyuridine (IDU) in treatment of herpes simplex keratitis.
August 1962, Archives of ophthalmology (Chicago, Ill. : 1960),
S P HALL-SMITH, and M J CORRIGAN, and M J GILKES
Clinical cure of herpes simplex keratitis by 5-iodo-2-deoxyuridine.
February 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Copied contents to your clipboard!